Yoon, W. J., Oh, Y., Yoo, C., Jang, S., Cho, S., Suh, J., . . . Park, D. H. (2020). EUS-Guided Versus Percutaneous Celiac Neurolysis for the Management of Intractable Pain Due to Unresectable Pancreatic Cancer: A Randomized Clinical Trial. Journal of Clinical Medicine, 9(6), 1666. https://doi.org/10.3390/jcm9061666
Chicago Style (17th ed.) CitationYoon, Won Jae, Yul Oh, Changhoon Yoo, Sunguk Jang, Seong-Sik Cho, Jeong-Hun Suh, Seong-Soo Choi, and Do Hyun Park. "EUS-Guided Versus Percutaneous Celiac Neurolysis for the Management of Intractable Pain Due to Unresectable Pancreatic Cancer: A Randomized Clinical Trial." Journal of Clinical Medicine 9, no. 6 (2020): 1666. https://doi.org/10.3390/jcm9061666.
MLA (9th ed.) CitationYoon, Won Jae, et al. "EUS-Guided Versus Percutaneous Celiac Neurolysis for the Management of Intractable Pain Due to Unresectable Pancreatic Cancer: A Randomized Clinical Trial." Journal of Clinical Medicine, vol. 9, no. 6, 2020, p. 1666, https://doi.org/10.3390/jcm9061666.